Literature DB >> 1901959

Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies.

A L Hillman, J M Eisenberg, M V Pauly, B S Bloom, H Glick, B Kinosian, J S Schwartz.   

Abstract

Mesh:

Year:  1991        PMID: 1901959     DOI: 10.1056/NEJM199105093241911

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  64 in total

Review 1.  Pharmacoeconomic evaluation of new treatments: efficacy versus effectiveness studies?

Authors:  C Bombardier; A Maetzel
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  Methodological hurdles in conducting pharmacoeconomic analyses.

Authors:  J D Rizzo; N R Powe
Journal:  Pharmacoeconomics       Date:  1999-04       Impact factor: 4.981

Review 3.  Conflict of interest in industry-sponsored economic evaluations: real or imagined?

Authors:  M Barbieri; M F Drummond
Journal:  Curr Oncol Rep       Date:  2001-09       Impact factor: 5.075

Review 4.  Pharmacoeconomic fellowships: the need for outcome measures.

Authors:  V Maio; T K Girts; J H Lofland; D B Nash
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

5.  The problem of protocol driven costs in pharmacoeconomic analysis.

Authors:  D Coyle; K M Lee
Journal:  Pharmacoeconomics       Date:  1998-10       Impact factor: 4.981

6.  A reappraisal of economic evaluation of pharmaceuticals. Science or marketing?

Authors:  M F Drummond
Journal:  Pharmacoeconomics       Date:  1998-07       Impact factor: 4.981

Review 7.  The role of government and private insurers in guiding and implementing pharmacoeconomic analyses.

Authors:  D A Freund; B R Luce
Journal:  Pharmacoeconomics       Date:  1998-04       Impact factor: 4.981

8.  Applied pharmacoeconomics. When can publication be legitimately withheld?

Authors:  G C Yee; A L Hillman
Journal:  Pharmacoeconomics       Date:  1997-11       Impact factor: 4.981

Review 9.  Why training is the key to successful guideline implementation.

Authors:  A D Paltiel; P J Neumann
Journal:  Pharmacoeconomics       Date:  1997-09       Impact factor: 4.981

10.  Principles of pharmacoeconomic analysis of drug therapy.

Authors:  D A Freund; R S Dittus
Journal:  Pharmacoeconomics       Date:  1992-01       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.